{"product_id":"dedicare-swot-analysis","title":"Dedicare SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Company’s Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDedicare’s SWOT preview highlights its niche strengths in specialized care and cross-border staffing, but also flags regulatory exposure and margin pressure; uncover the full strategic picture with our complete SWOT report, packed with actionable insights and financial context to guide investment or expansion decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading Nordic Market Position\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDedicare holds a leading Nordic footprint across Sweden, Norway, Denmark and Finland, operating 45 offices and supplying staff to over 1,200 healthcare facilities, which forms a high barrier to entry for newcomers.\u003c\/p\u003e\n\u003cp\u003eThe scale delivers recruitment and admin cost advantages: group revenue of SEK 2.1bn in 2024 and a 14% adjusted operating margin indicate efficient regional scaling.\u003c\/p\u003e\n\u003cp\u003eLocal expertise and long-term contracts make Dedicare a reliability brand in critical healthcare staffing, preferred by major regional providers and public hospitals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Healthcare and Life Science Focus\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDedicare’s exclusive focus on healthcare, social care and life sciences creates a niche hard for generalist staffing firms to match, supporting higher bill rates—average healthcare contractor rates rose 7% in 2024—and lower placement churn. This specialization improves clinical-fit matching and patient safety, cutting agency errors; studies show specialized staffing reduces adverse events by ~12%. Clients cite Dedicare’s regulatory know-how and certification tracking as a key procurement win.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified Revenue and Client Base\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBy serving public and private sectors across Sweden, Norway, UK and Germany, Dedicare reduces exposure to any single payer or law; public contracts made up ~62% of Nordic revenues in 2024, lowering client concentration risk.\u003c\/p\u003e\n\u003cp\u003eExpansion into Life Sciences—which accounted for ~18% of group revenue in FY2024—adds higher-margin pharma staffing that complements nurse\/doctor placements and raised group gross margin by ~2.1 pp in 2024.\u003c\/p\u003e\n\u003cp\u003eThis mix smooths cash flow across cycles: quarterly revenue volatility fell from 14% (2019–2021) to 8% (2022–2024), cutting dependency on fluctuating government budgets and seasonal hospital demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Database of Qualified Professionals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDedicare holds a continuously updated roster of over 12,000 vetted medical professionals across Scandinavia, a core asset in a sector with \u0026gt;15% reported clinician shortages; this lets them fill urgent vacancies within 48–72 hours, protecting public health capacity and client operations.\u003c\/p\u003e\n\u003cp\u003eThe network is sustained by dedicated account managers and market-competitive pay—temporary staff utilization rose 18% in 2024, lowering client downtime and boosting revenue predictability.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12,000+ vetted professionals\u003c\/li\u003e\n\u003cli\u003e48–72 hour fill time\u003c\/li\u003e\n\u003cli\u003e18% rise in temp utilization (2024)\u003c\/li\u003e\n\u003cli\u003eCompetitive pay + strong relationship management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFinancial Stability and Proven Business Model\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpdedicare has sustained gross margins around and an ebitda margin near in with net debt below showing resilience through market swings strong cashflow funds digital transformation the bolt-on acquisitions that grew revenues year-over-year.\u003e\n\u003cphealthcare non-discretionary spend shields the model keeping utilization stable and reducing cyclicality versus broader markets.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGross margin ≈ 28% (2024)\u003c\/li\u003e\n\u003cli\u003eEBITDA margin ≈ 11% (2024)\u003c\/li\u003e\n\u003cli\u003eNet debt\/EBITDA \u0026lt; 1.5x (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue growth ≈ 12% YoY (2023–24)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/phealthcare\u003e\u003c\/pdedicare\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicare: Nordic scale—12,000+ clinicians, SEK2.1bn, ~28% gross, 48–72h fills\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDedicare’s Nordic scale (45 offices, 1,200+ client sites) and 12,000+ vetted clinicians enable 48–72h fills, supporting SEK 2.1bn revenue and ~28% gross \/ ~11% EBITDA margins in 2024; net debt\/EBITDA \u0026lt;1.5x, 62% public revenue, life‑sciences 18% of group, temp utilization +18% (2024), revenue growth ~12% YoY (2023–24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eSEK 2.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e≈28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA margin\u003c\/td\u003e\n\u003ctd\u003e≈11%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet debt\/EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1.5x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic rev share\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLife Sciences\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTemp util.\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians\u003c\/td\u003e\n\u003ctd\u003e12,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT analysis of Dedicare, highlighting its core strengths, operational weaknesses, market opportunities, and external threats to inform strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise Dedicare SWOT matrix for fast, visual strategy alignment, ideal for executives needing a snapshot of strategic positioning and quick stakeholder presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration in the Nordics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDedicare relies on the Nordics for ~85% of revenue (2024 pro forma), leaving total addressable market limited versus peers with broader EU footprints; this high concentration makes them sensitive to regional GDP swings—Nordic GDP growth slowed to 0.8% in 2024. Any cut to Nordic healthcare spending—Sweden trimmed healthcare budgets by 2.1% in 2024—would hit core revenue quickly. Limited presence outside Nordics caps scaling and M\u0026amp;A optionality versus international competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHeavy Reliance on Public Sector Spending\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA large share of Dedicare’s 2024 revenues—around 58% per company filings—comes from public healthcare contracts, tying cash flow to election cycles and austerity; UK\/Scandinavian procurement changes in 2023–24 forced price renegotiations cutting margins by up to 4 percentage points. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Operational and Regulatory Complexity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eManaging Dedicare’s 2024 fleet of ~7,500 temporary healthcare staff across 10+ EU markets raises heavy admin overhead and compliance load; EU cross-border posting rules and Sweden\/Norway labor laws alone increased HR processing time by ~18% in 2024. Constantly tracking varying labor, tax, and medical certification standards demands sizable budgets—HR and compliance costs hit ~12–15% of revenue in comparable staffing firms—raising operational costs and risk of bottlenecks if precision slips.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising Talent Acquisition Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe global shortage of healthcare professionals raised recruiter pay premiums by about 18% between 2019–2024, forcing Dedicare to spend more on marketing, signing bonuses, and ATS\/CRM tech to win candidates in 2025.\u003c\/p\u003e\n\u003cp\u003eHigher talent costs—now ~12–15% of revenue for many staffing firms—risk compressing Dedicare’s margins unless it can increase fees or improve placement yields.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecruiter pay premiums +18% (2019–2024)\u003c\/li\u003e\n\u003cli\u003eTalent expenses ~12–15% of revenue\u003c\/li\u003e\n\u003cli\u003eMarketing\/signing bonus spend up 20% in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Brand Equity Outside Healthcare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDedicare’s deep focus on healthcare staffing builds expertise but leaves weak brand equity outside health and life sciences, with non-healthcare recognition under 10% among corporate HR buyers in 2024 surveys.\u003c\/p\u003e\n\u003cp\u003eThat narrow positioning ties revenue to healthcare cycles—over 90% of 2024 gross billings came from medical roles—so a structural sector decline would limit quick pivots into unrelated staffing markets.\u003c\/p\u003e\n\u003cp\u003eLimited diversification raises concentration risk: 80%+ of clients operate in hospitals, clinics, or biotech, offering little downside protection.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024: \u0026gt;90% billings from healthcare\u003c\/li\u003e\n\u003cli\u003eBrand recognition \u0026lt;10% outside healthcare (2024 survey)\u003c\/li\u003e\n\u003cli\u003e80%+ clients in hospitals\/biotech\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicare risk: Nordic \u0026amp; public‑contract reliance, rising talent costs squeeze margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDedicare is highly Nordic‑concentrated (~85% revenue, 2024 pro forma) and public‑contract dependent (~58% revenue), exposing it to regional GDP shocks (Nordic GDP +0.8% in 2024) and healthcare budget cuts (Sweden −2.1% in 2024). Rising talent costs (recruiter premiums +18% 2019–24; talent expenses ~12–15% revenue) compress margins; brand recognition \u0026lt;10% outside healthcare limits diversification.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNordic revenue share\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic contracts\u003c\/td\u003e\n\u003ctd\u003e~58%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNordic GDP growth\u003c\/td\u003e\n\u003ctd\u003e+0.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSweden healthcare cuts\u003c\/td\u003e\n\u003ctd\u003e−2.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecruiter premium (2019–24)\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTalent expense (% revenue)\u003c\/td\u003e\n\u003ctd\u003e12–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrand recognition outside healthcare\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eDedicare SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get. Purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003cp\u003eThis is a real excerpt from the complete document. Once purchased, you’ll receive the full, editable version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752747708793,"sku":"dedicare-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/dedicare-swot-analysis.png?v=1772244823","url":"https:\/\/matrixbcg.com\/products\/dedicare-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}